Albumin: Biochemical properties and therapeutic potential
暂无分享,去创建一个
[1] W. Dröge. Aging-related changes in the thiol/disulfide redox state: implications for the use of thiol antioxidants , 2002, Experimental Gerontology.
[2] P. Karplus,et al. Protein sulfenic acids in redox signaling. , 2004, Annual review of pharmacology and toxicology.
[3] S. Barnes,et al. Sulfenic acid formation in human serum albumin by hydrogen peroxide and peroxynitrite. , 2003, Biochemistry.
[4] J. Grangé,et al. Nitric oxide and renal function in cirrhotic patients with ascites: from physiopathology to practice , 2004, European journal of gastroenterology & hepatology.
[5] M. Miyamoto,et al. Effect of nitric oxide on the ligand-binding activity of albumin. , 1997, Archives of biochemistry and biophysics.
[6] M. Wilkes,et al. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. , 2001, Annals of internal medicine.
[7] G. Bernard,et al. Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury* , 2002, Critical care medicine.
[8] J. Vincent. Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement. , 2004, American journal of respiratory and critical care medicine.
[9] L. Brochard,et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study , 2001, The Lancet.
[10] V. Preedy,et al. Liver albumin synthesis in sepsis in the rat: influence of parenteral nutrition, glutamine and growth hormone. , 2003, Clinical science.
[11] C. Tetta,et al. OXIDATION OF ALBUMIN IS ENHANCED IN THE PRESENCE OF UREMIC TOXINS , 2001, Renal failure.
[12] J. Marshall,et al. Twenty-five percent albumin prevents lung injury following shock/resuscitation , 2003, Critical care medicine.
[13] P. Rhee,et al. Effect of different resuscitation strategies on neutrophil activation in a swine model of hemorrhagic shock. , 2004, Resuscitation.
[14] H. E. Marshall,et al. Essential Roles of S-Nitrosothiols in Vascular Homeostasis and Endotoxic Shock , 2004, Cell.
[15] H. Powers,et al. Iron-binding antioxidant potential of plasma albumin. , 1997, Clinical science.
[16] P. Essén,et al. Tissue protein synthesis rates in critically ill patients. , 1998, Critical care medicine.
[17] A. Cantin,et al. Albumin-mediated regulation of cellular glutathione and nuclear factor kappa B activation. , 2000, American journal of respiratory and critical care medicine.
[18] D. Cook,et al. Crystalloids vs. colloids in fluid resuscitation: a systematic review. , 1999, Critical care medicine.
[19] J. Stamler,et al. In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. , 1994, The Journal of clinical investigation.
[20] R. Craig,et al. Albumin kinetics in hypoalbuminemic patients receiving total parenteral nutrition. , 1996, JPEN. Journal of parenteral and enteral nutrition.
[21] V. Arroyo. Review article: albumin in the treatment of liver diseases—new features of a classical treatment , 2002, Alimentary pharmacology & therapeutics.
[22] A. Gramowski,et al. Improvement in Central Nervous System Functions During Treatment of Liver Failure with Albumin Dialysis MARS—A Review of Clinical, Biochemical, and Electrophysiological Data , 2002, Metabolic Brain Disease.
[23] B. Ames,et al. Antioxidant activity of albumin-bound bilirubin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[24] B. Halliwell,et al. Free radicals in biology and medicine , 1985 .
[25] T. Cosgrove,et al. Reaction of xanthine oxidase-derived oxidants with lipid and protein of human plasma. , 1991, Archives of biochemistry and biophysics.
[26] M. Luyckx,et al. Antioxidant properties of albumin: effect on oxidative metabolism of human neutrophil granulocytes. , 1999, Farmaco.
[27] K. Fukuoka,et al. Hypoalbuminemia accelerates erythrocyte membrane lipid peroxidation in chronic hemodialysis patients. , 1999, Clinical nephrology.
[28] C. Hubel,et al. Binding of fatty acids facilitates oxidation of cysteine-34 and converts copper-albumin complexes from antioxidants to prooxidants. , 2003, Archives of biochemistry and biophysics.
[29] Robyn Norton,et al. A comparison of albumin and saline for fluid resuscitation in the Intensive Care unit , 2005 .
[30] Roger Williams,et al. Albumin dialysis and molecular adsorbents recirculating system (MARS) for acute Wilson's disease , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[31] P. Tessari. Protein metabolism in liver cirrhosis: from albumin to muscle myofibrils , 2003, Current opinion in clinical nutrition and metabolic care.
[32] T. Peters,et al. All About Albumin: Biochemistry, Genetics, and Medical Applications , 1995 .
[33] C. Coudray,et al. Vanadium and copper in clinical solutions of albumin and their potential to damage protein structure. , 1992, Journal of pharmaceutical sciences.
[34] R. Bellomo,et al. The SAFE study: saline vs. albumin for fluid resuscitation in the critically ill , 2004, Vox sanguinis.
[35] G. Martin,et al. Understanding and managing fluid balance in patients with acute lung injury , 2004, Current opinion in critical care.
[36] Roger Williams,et al. Liver failure: basis of benefit of therapy with the molecular adsorbents recirculating system. , 2003, The international journal of biochemistry & cell biology.
[37] S. S. Schreiber,et al. Albumin synthesis. 1. , 1972, The New England journal of medicine.
[38] H. Barle,et al. Albumin synthesis in humans increases immediately following the administration of endotoxin. , 2002, Clinical science.
[39] I. Marino,et al. Effect of molecular adsorbent recirculating system in hepatitis C virus‐related intractable pruritus , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[40] G. Bernard,et al. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury* , 2004, Critical care medicine.
[41] W. Buylaert,et al. Pharmacokinetic and Pharmacodynamic Considerations When Treating Patients with Sepsis and Septic Shock , 2002, Clinical pharmacokinetics.
[42] T. Sauerbruch,et al. Inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) expression in fulminant hepatic failure. , 2002, Journal of hepatology.
[43] P. Saltman,et al. Zinc(II) and copper(II) binding to serum albumin. A comparative study of dog, bovine, and human albumin. , 1994, The Journal of biological chemistry.
[44] J. Rodés,et al. Extracorporeal Albumin Dialysis: A Procedure for Prolonged Relief of Intractable Pruritus in Patients with Primary Biliary Cirrhosis , 2004, American Journal of Gastroenterology.
[45] T. Evans,et al. Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. , 1998, Clinical science.
[46] W. E. Reynolds,et al. Studies of I-131-albumin catabolism and distribution in normal young male adults. , 1962, The Journal of clinical investigation.
[47] G. Park,et al. The role of albumin in critical illness. , 2000, British journal of anaesthesia.
[48] D. Carter,et al. The atomic structure of human methemalbumin at 1.9 A. , 2002, Biochemical and biophysical research communications.
[49] M. Gladwin,et al. Biological activity of nitric oxide in the plasmatic compartment. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[50] G. Peek,et al. Modular extracorporeal life support for multiorgan failure patients. , 2002, Liver.
[51] S. S. Schreiber,et al. Extravascular albumin. , 1979, The New England journal of medicine.
[52] J. Janatova,et al. The heterogeneity of bovine albumin with respect to sulfhydryl and dimer content. , 1968, The Journal of biological chemistry.
[53] S. Barnes,et al. Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives. , 1995, Archives of biochemistry and biophysics.
[54] R. Stocker,et al. Bilirubin attenuates radical‐mediated damage to serum albumin , 1993, FEBS letters.
[55] S. Matalon,et al. Oxidant-antioxidant balance in acute lung injury. , 2002, Chest.
[56] J. Gutteridge,et al. Copper salt-dependent hydroxyl radical formation. Damage to proteins acting as antioxidants. , 1983, Biochimica et biophysica acta.
[57] J. Gutteridge,et al. Antioxidant protection by haemopexin of haem-stimulated lipid peroxidation. , 1988, The Biochemical journal.
[58] Carlo Bertucci,et al. Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance. , 2002, Current medicinal chemistry.
[59] S. Mitzner,et al. Experiences with MARS liver support therapy in liver failure: analysis of 176 patients of the International MARS Registry. , 2002, Liver.
[60] M. Eichner,et al. Certain batches of albumin solutions influence the expression of endothelial cell adhesion molecules , 1999, Intensive Care Medicine.
[61] P. Dodek,et al. Distribution of normal saline and 5% albumin infusions in septic patients. , 1999, Critical care medicine.
[62] J. Doweiko,et al. Use of albumin as a volume expander. , 1991, JPEN. Journal of parenteral and enteral nutrition.
[63] U. Muller-eberhard,et al. The influence of heme-binding proteins in heme-catalyzed oxidations. , 1988, Archives of Biochemistry and Biophysics.
[64] Cochrane Injuries,et al. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. , 1998, BMJ.
[65] N. Soni,et al. Changes in serum albumin concentration and volume expanding effects following a bolus of albumin 20% in septic patients. , 2004, British journal of anaesthesia.
[66] M. Otagiri,et al. Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. , 2002, Biological & pharmaceutical bulletin.
[67] J. Haddad. Oxygen homeostasis, thiol equilibrium and redox regulation of signalling transcription factors in the alveolar epithelium. , 2002, Cellular signalling.
[68] M. Navasa,et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. , 1999, The New England journal of medicine.
[69] A. Berger. Cochrane Injuries Group Albumin ReviewersWhy albumin may not work , 1998 .